Circ_0114428 promotes proliferation, fibrosis and EMT process of high glucose-induced glomerular mesangial cells through regulating the miR-185-5p/SMAD3 axis

References

• Qi C, Mao X, Zhang Z, et al. Classification and differential diagnosis of diabetic nephropathy. J Diabetes Res. 2017;2017:8637138.
   PubMed Web of Science ®Google Scholar
• Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci (Lond). 2013;124(3):139–152.
   PubMed Web of Science ®Google Scholar
• Kanwar YS, Sun L, Xie P, et al. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol. 2011;6:395–423.
   PubMed Web of Science ®Google Scholar
• Dai H, Liu Q, Liu B. Research progress on mechanism of podocyte depletion in diabetic nephropathy. J Diabetes Res. 2017;2017:2615286.
   PubMed Web of Science ®Google Scholar
• Tung CW, Hsu YC, Shih YH, et al. Glomerular mesangial cell and podocyte injuries in diabetic nephropathy. Nephrology (Carlton). 2018;23(Suppl 4):32–37.
   PubMed Web of Science ®Google Scholar
• Nakajima T, Hasegawa G, Kamiuchi K, et al. Differential regulation of intracellular redox state by extracellular matrix proteins in glomerular mesangial cells: potential role in diabetic nephropathy. Redox Rep. 2006;11(5):223–230.
   PubMed Web of Science ®Google Scholar
• Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4):381–388.
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691.
   PubMed Web of Science ®Google Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388.
   PubMed Web of Science ®Google Scholar
• Panda AC. Circular RNAs act as miRNA sponges. Adv Exp Med Biol. 2018;1087:67–79.
   PubMed Web of Science ®Google Scholar
• Miao L, Yin RX, Zhang QH, et al. A novel circRNA-miRNA-mRNA network identifies circ-YOD1 as a biomarker for coronary artery disease. Sci Rep. 2019;9(1):18314.
   PubMedGoogle Scholar
• Chen X, Ouyang Z, Shen Y, et al. CircRNA_28313/miR-195a/CSF1 axis modulates osteoclast differentiation to affect OVX-induced bone absorption in mice. RNA Biol. 2019;16(9):1249–1262.
   PubMed Web of Science ®Google Scholar
• Cheng J, Zhuo H, Xu M, et al. Regulatory network of circRNA-miRNA-mRNA contributes to the histological classification and disease progression in gastric cancer. J Transl Med. 2018;16(1):216.
   PubMed Web of Science ®Google Scholar
• Chen B, Li Y, Liu Y, et al. circLRP6 regulates high glucose-induced proliferation, oxidative stress, ECM accumulation, and inflammation in mesangial cells. J Cell Physiol. 2019;234(11):21249–21259.
   PubMed Web of Science ®Google Scholar
• Ge X, Xi L, Wang Q, et al. Circular RNA circ_0000064 promotes the proliferation and fibrosis of mesangial cells via miR-143 in diabetic nephropathy. Gene. 2020;758:144952.
   PubMed Web of Science ®Google Scholar
• Wang Q, Cang Z, Shen L, et al. Circ_0037128/miR-17-3p/AKT3 axis promotes the development of diabetic nephropathy. Gene. 2021;765:145076.
   PubMed Web of Science ®Google Scholar
• He Y, Sun Y, Peng J. Circ_0114428 regulates sepsis-induced kidney injury by targeting the miR-495-3p/CRBN axis. Inflammation. 2021;44(4):1464–1477.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang W, HuangFu W, et al. LncRNA HOTAIR facilitates high glucose-induced mesangial cell proliferation, fibrosis and oxidative stress in diabetic nephropathy via regulating miR-147a/WNT2B axis. Diabetol Metab Syndr. 2022;14(1):33.
   PubMedGoogle Scholar
• Geng Z, Dong B, Lv W, et al. LncRNA ZFAS1 regulates the proliferation, oxidative stress, fibrosis, and inflammation of high glucose-induced human mesangial cells via the miR-588/ROCK1 axis. Diabetol Metab Syndr. 2022;14(1):21.
   PubMedGoogle Scholar
• Sun A, Sun N, Liang X, et al. Circ-FBXW12 aggravates the development of diabetic nephropathy by binding to miR-31-5p to induce LIN28B. Diabetol Metab Syndr. 2021;13(1):141.
   PubMed Web of Science ®Google Scholar
• Wan H, Wang Y, Pan Q, et al. Quercetin attenuates the proliferation, inflammation, and oxidative stress of high glucose-induced human mesangial cells by regulating the miR-485-5p/YAP1 pathway. Int J Immunopathol Pharmacol. 2022;36:20587384211066440.
   Google Scholar
• Liu Z, Yu Y, Huang Z, et al. CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression. Cell Death Dis. 2019;10(12):900.
   PubMed Web of Science ®Google Scholar
• Li H, Xu JD, Fang XH, et al. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4. Cardiovasc Res. 2020;116(7):1323–1334.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Xu J, Liang W, et al. miR-98-5p alleviated epithelial-to-mesenchymal transition and renal fibrosis via targeting Hmga2 in diabetic nephropathy. Int J Endocrinol. 2019;2019:4946181.
   PubMed Web of Science ®Google Scholar
• Li B, Sun G, Yu H, et al. Exosomal circTAOK1 contributes to diabetic kidney disease progression through regulating SMAD3 expression by sponging miR-520h. Int Urol Nephrol. 2022. [cited 2022 Feb 10]. DOI: 10.1007/s11255-022-03139-y.
   Google Scholar
• Hou Y, Zhang Y, Lin S, et al. Protective mechanism of ­apigenin in diabetic nephropathy is related to its regulation of miR-423-5P-USF2 axis. Am J Transl Res. 2021;13(4):2006–2020.
   PubMed Web of Science ®Google Scholar
• Cao Y, Zhang R, Luo X, et al. LncRNA PART1 promotes lung squamous cell carcinoma progression via miR-185-5p/Six1 axis. Hum Exp Toxicol. 2021;40(6):960–976.
   PubMedGoogle Scholar
• Sun W, Nie W, Wang Z, et al. Lnc HAGLR promotes colon cancer progression through sponging miR-185-5p and activating CDK4 and CDK6 in vitro and in vivo. Onco Targets Ther. 2020;13:5913–5925.
   PubMed Web of Science ®Google Scholar
• Sun W, Zu S, Shao G, et al. LncRNA DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 (LASP1) promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/Snail pathway. J Gene Med. 2021;23(7):e3344.
   PubMed Web of Science ®Google Scholar
• Yuan Q, Xu T, Chen Y, et al. MiR-185-5p ameliorates endoplasmic reticulum stress and renal fibrosis by downregulation of ATF6. Lab Invest. 2020;100(11):1436–1446.
   PubMedGoogle Scholar
• Li G, Qin Y, Qin S, et al. Circ_WBSCR17 aggravates inflammatory responses and fibrosis by targeting miR-185-5p/SOX6 regulatory axis in high glucose-induced human kidney tubular cells. Life Sci. 2020;259:118269.
   PubMed Web of Science ®Google Scholar
• Hu W, Han Q, Zhao L, et al. Circular RNA circRNA_15698 aggravates the extracellular matrix of diabetic nephropathy mesangial cells via miR-185/TGF-beta1. J Cell Physiol. 2019;234(2):1469–1476.
   PubMed Web of Science ®Google Scholar
• Liu R, Zhang M, Ge Y. Circular RNA HIPK3 exacerbates diabetic nephropathy and promotes proliferation by sponging miR-185. Gene. 2021;765:145065.
   PubMed Web of Science ®Google Scholar
• Xu BH, Sheng J, You YK, et al. Deletion of Smad3 prevents renal fibrosis and inflammation in type 2 diabetic nephropathy. Metabolism. 2020;103:154013.
   PubMed Web of Science ®Google Scholar
• Wang P, Luo ML, Song E, et al. Long noncoding RNA lnc-TSI inhibits renal fibrogenesis by negatively regulating the TGF-beta/Smad3 pathway. Sci Transl Med. 2018;10(462):eaat2039.
   Google Scholar
• Zhu QJ, Zhu M, Xu XX, et al. Exosomes from high glucose-treated macrophages activate glomerular mesangial cells via TGF-beta1/Smad3 pathway in vivo and in vitro. Faseb J. 2019;33(8):9279–9290.
   PubMedGoogle Scholar
• Wang X, Feng S, Fan J, et al. New strategy for renal fibrosis: targeting Smad3 proteins for ubiquitination and degradation. Biochem Pharmacol. 2016;116:200–209.
   PubMed Web of Science ®Google Scholar